Article
FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease
Rating:
0.0
Views:
55
Likes:
1
Library:
1
Most people with sickle cell disease who received a new gene editing treatment saw their pain resolve for at least one year, but longer follow up is needed
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value